Mature B-cell leukemias with more than 55% prolymphocytes: A heterogeneous group that includes an unusual variant of mantle cell lymphoma

American Journal of Clinical Pathology

Volumn 115, Issue 4, 2001, Pages 571-581

  Schlette, Ellen ^a   Bueso Ramos, Carlos ^a   Giles, Francis ^a   Glassman, Armand ^a   Hayes, Kimberly ^a   Medeiros, L Jeffrey ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Chronic lymphocytic leukemia; Cyclin D1; Immunophenotype; Mantle cell lymphoma; Prolymphocytic leukemia; t(11; 14)

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD; BONE MARROW; CHROMOSOME 7; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; KARYOTYPE; MALE; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROLYMPHOCYTE; TRISOMY 12;

AGED; AGED, 80 AND OVER; ANTIGENS, CD5; BONE MARROW CELLS; CELL SEPARATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 7; CYCLIN D1; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTES; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, IGE; TRISOMY;

EID: 0035057260     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/PPK0-TJUK-1UAR-3194     Document Type: Article

References (35)

1. Galton G, Goldman J, Wiltshaw E, et al. Prolymphocytic leukemia. Br J Haematol. 1974;27:7-23.
2. Enno A, Catovsky D, O'Drien M, et al. "Prolymphocytoid" transformation of chronic lymphocytic leukemia. Br J Haematol. 1979;41:9-18.
3. Kjeldsberg CR, Marty J. Prolymphocytic transformation of chronic lymphocytic leukemia. Cancer. 1981;48:2447-2457.
4. Melo JV, Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia, I: clinical and laboratory features of 300 patients and characterization of an intermediate group. Br J Haematol. 1986;63:377-387.
5. Melo JV, Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia, II: patterns of evolution of "prolymphocytoid" transformation. Br J Haematol. 1986;64:77-86.
6. Melo JV, Wardle J, Chetty M, et al. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia, III: evaluation of cell size by morphology and volume measurements. Br J Haematol. 1986;64:469-478.
7. Melo J, Catovsky D, Gregory WM, et al. The relationship between chronic lymphocytic leukemia and prolymphocytic leukemia, IV: analysis of survival and prognostic features. Br J Haematol. 1987;65:23-29.
8. Bennett J, Catovsky D, Daniel M-T, et al, for the French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989;42:567-584.
9. Bain B. Leukemia Diagnosis: A Guide to the FAB Classification. Philadelphia, PA: Lippincott; 1990:92-93.
10. Shvidel L, Shtalrid M, Bassous L, et al. B-cell prolymphocytic leukemia: a survey of 35 patients emphasizing heterogeneity, prognostic factors and evidence for a group with an indolent course. Leuk Lymphoma. 1999;35:169-179.
11. Brito-Babapulle V, Pittman S, Melo J, et al. Cytogenetic studies on prolymphocytic leukemia, I: B-cell prolymphocytic leukemia. Hematol Pathol. 1987;1:27-32.
12. Juliusson G, Robert K-H, Ost A, et al. Del(3)(p13) in B-prolymphocytic leukemia: a new nonrandom chromosomal aberration possibly related to the c-ras oncogene. Cancer Genet Cytogenet. 1985;14:191-195.
13. Lens D, De Schouwer P, Hamoudi R, et al. p53 abnormalities in B-cell prolymphocytic leukemia. Blood. 1997;89:2015-2023.
14. Pittman S, Catovsky D. Chromosome abnormalities in B-cell prolymphocytic leukemia: a study of nine cases. Cancer Genet Cytogenet. 1983;9:355-365.
15. Solé F, Woessner S, Espinet B, et al. Cytogenetic abnormalities in three patients with B-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 1998;103:43-45.
16. Solé F, Woessner S, Perez-Losada A, et al. Cytogenetic studies in seventy-six cases of B-chronic lymphocytic disorders. Cancer Genet Cytogenet. 1997;93:160-166.
17. Nakamura S, Yatabe Y, Seto M. Cyclin D1 overexpression in malignant lymphomas. Pathol Int. 1997;47:421-429.
18. Zoldan MC, Inghirami G, Masuda Y, et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol. 1996;93:475-486.
19. Wang K-F, Chan JKC, SoJCC, et al. Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer. 1999;86:850-837.
20. Borowitz MJ, Guenther KL, Shults GT. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
21. Mitelman F, ed. ISCN 1995: An International System for Human Cytogenetic Nomenclature 1995. Basel, Switzerland: Karger; 1995.
22. Brito-Babapulle V, Ellis J, Matutes E, et al. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer. 1992;5:158-165.
23. Khouri IF, Romaguera J, Kantarjian H, et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol. 1998;16:3803-3809.
24. Levy V, Ugo F, Delmer A, et al. Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder. Leukemia. 1999;13:1343-1351.
25. Singleton TP, Anderson MM, Ross CW, et al. Leukemic phase of mantle cell lymphoma, blastoid variant. Am J Clin Pathol. 1999;11:495-500.
26. Viswanatha DS, Foucar K, Berry BR, et al. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol. 2000;13:825-833.
27. Kantarjian HM, Childs C, O'Brien S, et al. Efficacy of fludarabine, a new adenine nucleoside analogue, in patients with prolymphocytic leukemia and the prolymphocytic variant of chronic lymphocytic leukemia. Am J Med. 1991;90:223-228.
28. Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.
29. Nieto LH, Lampert IA, Catovsky D. Bone marrow histological patterns in B-cell and T-cell prolymphocytic leukemia. Hematol Pathol. 1989;3:79-84.
30. Batata A, Shen B. Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia: a study of 242 cases. Cancer. 1992;70:2436-2443.
31. Hernandez J, Mecucci C, Criel A, et al. Cytogenetic analysis of B-cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia. 1995;9:2140-2146.
32. Mitelman F. Catalog of Chromosome Aberrations in Cancer. 5th ed. New York, NY: Wiley-Liss; 1994.
33. Hernandez J, Mecucci C, Michaux L, et al. del(7q) in chronic B-cell lymphoid malignancies. Cancer Genet Cytogenet. 1997;93:147-151.
34. Gaidano G, Ballerini P, Gong J, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1991;88:5413-5417.
35. Greiner T, Moynihan M, Chan W, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood. 1996;87:4302-4310.